Clearline Capital’s LivaNova LIVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-180,137
Closed -$7.08M 127
2025
Q1
$7.08M Buy
+180,137
New +$8.08M 0.43% 47
2024
Q2
Sell
-499,339
Closed -$27.9M 155
2024
Q1
$27.9M Sell
499,339
-55,324
-10% -$2.87M 1.36% 11
2023
Q4
$28.7M Buy
554,663
+99,301
+22% +$4.81M 1.76% 8
2023
Q3
$24.1M Sell
455,362
-99,950
-18% -$5.48M 2.07% 13
2023
Q2
$28.6M Hold
555,312
1.66% 7
2023
Q1
$24.2M Buy
555,312
+120,251
+28% +$6.09M 3.65% 5
2022
Q4
$24.2M Sell
435,061
-8,222
-2% -$420K 4.32% 3
2022
Q3
$22.5M Buy
443,283
+436,279
+6,229% +$25.9M 2.69% 9
2022
Q2
$438K Buy
+7,004
New +$496K 0.06% 111

Other funds holding LIVN

Clearline Capital's LIVN Position: Q2 2025 in Review

Clearline Capital sold out of LivaNova (LIVN) in Q2 2025, closing a stake of 180,137 shares — an estimated $7.08M sold.

Clearline Capital first reported a position in LIVN in Q2 2022 and held it in 9 quarters. The position peaked at $28.7M in Q4 2023. 252 funds tracked by Wall St. Rank hold LIVN as of Q2 2025.

  • Clearline Capital reported no remaining LivaNova position as of Q2 2025 after selling out during the quarter.
  • Clearline Capital sold 180,137 LivaNova shares in Q2 2025, an estimated $7.08M.
  • Clearline Capital first reported a position in LivaNova in Q2 2022 and held it in 9 quarters.
  • Clearline Capital's LivaNova position peaked at $28.7M in Q4 2023.
  • 252 funds tracked by Wall St. Rank held LivaNova as of Q2 2025.

Based on Clearline Capital's 13F filing for Q2 2025, filed 14 Aug 2025.